デジタルPCR（dPCR）の世界市場：2020年～2024年

世界のデジタルPCR（dPCR）市場は、2020年から2024年の予測期間中に11％のCAGRで成長し、2億5,226万米ドルの規模に達する見込みです。同市場は、病原体の検出と病気の診断におけるdPCRの使用の増加に牽引されています。さらに、ビーム技術ベースのdPCRワークフローの用途の拡大が、市場成長を後押しするものと予想されます。

当レポートでは、世界のデジタルPCR（dPCR）市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章レポートの範囲

• 序文
• 米ドルの通貨換算レート

第3章市場状況

• 市場のエコシステム
• 市場の特徴
• 市場セグメンテーション分析
• バリューチェーン分析

第4章 市場規模

• 市場の定義
• 市場規模2019
• 市場規模と予測2019-2024
• 市場の見通し

第5章 ファイブフォース分析

• バイヤーの交渉力
• サプライヤーの交渉力
• 新規参入者の脅威
• 代替品の脅威
• 競争相手の脅威
• 市況

第6章 製品別の市場セグメンテーション

• 市場セグメンテーション：製品別
• 比較：製品別
• 消耗品-市場規模と予測2019-2024
• 機器-市場規模および予測2019-2024
• 市場機会：製品別

第7章 顧客情勢

第8章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米-市場規模と予測2019-2024
• 欧州-市場規模と予測2019-2024
• アジア-2019-2024年の市場規模と予測
• 行-市場規模と予測2019-2024
• 主要な主要国
• 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

• 市場成長要因
• 市場の課題

第11章 市場動向

• ビーム技術ベースのdPCRワークフロー用途の拡大
• オーダーメイド医療の発展
• 非侵襲的出生前診断におけるdPCRの需要の増加

第12章 ベンダー情勢

• 概要
• 情勢の革新
• 競争シナリオ

第13章 ベンダー分析

• 対象ベンダー
• ベンダーの分類
• ベンダーの市場ポジショニング
• Bio-Rad Laboratories Inc.
• Expedeon AG
• Fluidigm Corp.
• JN Medsys
• Merck KGaA
• QIAGEN NV
• Stilla Technologies
• Sysmex Corp.
• Thermo Fisher Scientific Inc.

第14章 付録

• 調査方法
• 略語のリスト
• ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

LIST OF EXHIBITS:

• Exhibit 01: Global life sciences tools and services market
• Exhibit 02: Segments of global life sciences tools and services market
• Exhibit 03: Market characteristics
• Exhibit 04: Market segments
• Exhibit 05: Vendor offerings
• Exhibit 06: Market definition - Inclusions and exclusions checklist
• Exhibit 07: Market size 2019
• Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
• Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
• Exhibit 10: Five forces analysis 2019
• Exhibit 11: Five forces analysis 2024
• Exhibit 12: Bargaining power of buyers
• Exhibit 13: Bargaining power of suppliers
• Exhibit 14: Threat of new entrants
• Exhibit 15: Threat of substitutes
• Exhibit 16: Threat of rivalry
• Exhibit 17: Market condition - Five forces 2019
• Exhibit 18: Product - Market share 2019-2024 (%)
• Exhibit 19: Comparison by product
• Exhibit 20: Consumables - Market size and forecast 2019-2024 ($ millions)
• Exhibit 21: Consumables - Year-over-year growth 2020-2024 (%)
• Exhibit 22: Instruments - Market size and forecast 2019-2024 ($ millions)
• Exhibit 23: Instruments - Year-over-year growth 2020-2024 (%)
• Exhibit 24: Market opportunity by product
• Exhibit 25: Customer landscape
• Exhibit 26: Market share by geography 2019-2024 (%)
• Exhibit 27: Geographic comparison
• Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
• Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
• Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
• Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
• Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
• Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
• Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
• Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
• Exhibit 36: Key leading countries
• Exhibit 37: Market opportunity
• Exhibit 38: Impact of drivers and challenges
• Exhibit 39: Vendor landscape
• Exhibit 40: Landscape disruption
• Exhibit 41: Vendors covered
• Exhibit 42: Vendor classification
• Exhibit 43: Market positioning of vendors
• Exhibit 44: Bio-Rad Laboratories Inc. - Vendor overview
• Exhibit 45: Bio-Rad Laboratories Inc. - Business segments
• Exhibit 46: Bio-Rad Laboratories Inc. - Organizational developments
• Exhibit 47: Bio-Rad Laboratories Inc. - Geographic focus
• Exhibit 48: Bio-Rad Laboratories Inc. - Segment focus
• Exhibit 49: Bio-Rad Laboratories Inc. - Key offerings
• Exhibit 50: Expedeon AG - Vendor overview
• Exhibit 51: Expedeon AG - Business segments
• Exhibit 52: Expedeon AG - Organizational developments
• Exhibit 53: Expedeon AG - Geographic focus
• Exhibit 54: Expedeon AG - Key offerings
• Exhibit 55: Fluidigm Corp. - Vendor overview
• Exhibit 56: Fluidigm Corp. - Product segments
• Exhibit 57: Fluidigm Corp. - Organizational developments
• Exhibit 58: Fluidigm Corp. - Geographic focus
• Exhibit 59: Fluidigm Corp. - Key offerings
• Exhibit 60: JN Medsys - Vendor overview
• Exhibit 61: JN Medsys - Product segments
• Exhibit 62: JN Medsys - Key offerings
• Exhibit 63: Merck KGaA - Vendor overview
• Exhibit 64: Merck KGaA - Business segments
• Exhibit 65: Merck KGaA - Organizational developments
• Exhibit 66: Merck KGaA - Geographic focus
• Exhibit 67: Merck KGaA - Segment focus
• Exhibit 68: Merck KGaA - Key offerings
• Exhibit 69: QIAGEN NV - Vendor overview
• Exhibit 70: QIAGEN NV - Business segments
• Exhibit 71: QIAGEN NV - Organizational developments
• Exhibit 72: QIAGEN NV - Geographic focus
• Exhibit 73: QIAGEN NV - Segment focus
• Exhibit 74: QIAGEN NV - Key offerings
• Exhibit 75: Stilla Technologies - Vendor overview
• Exhibit 76: Stilla Technologies - Product segments
• Exhibit 77: Stilla Technologies - Organizational developments
• Exhibit 78: Stilla Technologies - Key offerings
• Exhibit 79: Sysmex Corp. - Vendor overview
• Exhibit 80: Sysmex Corp. - Business segments
• Exhibit 81: Sysmex Corp. - Organizational developments
• Exhibit 82: Sysmex Corp. - Geographic focus
• Exhibit 83: Sysmex Corp. - Segment focus
• Exhibit 84: Sysmex Corp. - Key offerings
• Exhibit 85: Thermo Fisher Scientific Inc. - Vendor overview
• Exhibit 86: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 87: Thermo Fisher Scientific Inc. - Organizational developments
• Exhibit 88: Thermo Fisher Scientific Inc. - Geographic focus
• Exhibit 89: Thermo Fisher Scientific Inc. - Segment focus
• Exhibit 90: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 91: Validation techniques employed for market sizing
• Exhibit 92: Definition of market positioning of vendors

Technavio has been monitoring the global digital PCR (dPCR) market and it is poised to grow by USD 252.26 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. Our reports on global digital PCR (dPCR) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing use of dPCR in pathogen detection and disease diagnosis. In addition, growing applications of beaming technology-based dPCR workflows is anticipated to boost the growth of the global digital PCR (dPCR) market as well.

Market Segmentation

Technavio's global digital PCR (dPCR) market is segmented as below:

Product

• Consumables
• Instruments

Geographic segmentation

• North America
• Europe
• Asia
• ROW

Key Trends for global digital PCR (dPCR) market growth

This study identifies growing applications of beaming technology-based dPCR workflows as the prime reasons driving the global digital PCR (dPCR) market growth during the next few years.

Prominent vendors in global digital PCR (dPCR) market

We provide a detailed analysis of around 25 vendors operating in the global digital PCR (dPCR) market, including some of the vendors such as Bio-Rad Laboratories Inc., Expedeon AG, Fluidigm Corp., JN Medsys, Merck KGaA, QIAGEN NV, Stilla Technologies, Sysmex Corp. and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

01: EXECUTIVE SUMMARY

02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Currency conversion rates for US$

03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis

04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook

05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Consumables - Market size and forecast 2019-2024
• Instruments - Market size and forecast 2019-2024
• Market opportunity by product

07: CUSTOMER LANDSCAPE

08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

09: DECISION FRAMEWORK

10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

11: MARKET TRENDS

• Growing applications of BEAMing technology-based dPCR workflows
• Growing developments in personalized medicine
• Growing demand for dPCR in non-invasive prenatal diagnosis

12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bio-Rad Laboratories Inc.
• Expedeon AG
• Fluidigm Corp.
• JN Medsys
• Merck KGaA
• QIAGEN NV
• Stilla Technologies
• Sysmex Corp.
• Thermo Fisher Scientific Inc.

14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

15: EXPLORE TECHNAVIO